Table 1.
Patients’ characteristics, n = 299.
| Age, Years, Median | 62.4 (IQR 51.5–70) |
| Sex | % (n) |
| Female | 28.1 (84) |
| Male | 79.9 (215) |
| Race | |
| Caucasian | 51.6 (154) |
| Latin American | 11 (33) |
| Asian | 0.3 (1) |
| African | 1 (3) |
| Arabic | 2.7 (8) |
| Unknown | 33.4 (100) |
| Smoking habit | 3.3 (10) |
| Comorbidities at hospital admission | |
| Hypertension | 40.8 (122) |
| Diabetes | 22.7 (68) |
| Asthma | 3 (9) |
| COPD | 4 (12) |
| Ischemic heart disease | 6.7 (20) |
| Valvular heart disease | 1 (3) |
| Auricular fibrillation | 3 (9) |
| Obesity | 36.1 (108) |
| Class 1 | 23.4 (70) |
| Class 2 | 8.7 (26) |
| Class 3 | 4 (12) |
| Hospitalization | Median (IQR) |
| Days from COVID-19 symptoms onset to hospital admission | 7 (5–9) |
| Length of hospital stay, days | 28 (18–42) |
| Time from hospital admission to ICU admission, days | 2 (0–5) |
| Length of ICU stay, days | 14 (7–28) |
| Blood tests results | |
| D-dimer | 1676 (779–4084) |
| Fibrinogen | 719 (608–861) |
| Leucocytes | 8.2 (IQR 5.6–12.4) |
| Lymphocytes | 0.6 (0.4–0.95) |
| Platelets | 201 (147–259) |
| Ferritin | 974 (482.1–1634) |
| C-reactive protein | 126 (69.6–207.6) |
| Prothrombin time (PT) | 12.9 (11.9–15.6) |
| IL6 | 71.3 (36.5–167.8) |
| Creatinine | 0.83 (0.68–1.23) |
| Procalcitonin | 0.25 (0.13–0.75) |
| Lactate dehydrogenase | 493.2 (315.5–734.5) |
| Aspartate dehydrogenase | 49 (30.1–80.2) |
| Alanine transaminase | 37.6 (22–71.2) |
| Doppler ultrasounds of the lower limb veins | 77.5 (232) |
| Thrombosis | 20.06 (60) |
| Deep vein thrombosis (DVT) | 10.6 (31) |
| Pulmonary embolism (PE) | 3.67 (11) |
| DVT + PE | 5.01 (15) |
| Stroke + DVT | 0.33 (1) |
| Stroke | 0.66 (2) |
| Anticoagulant therapy received | % (n) |
| Prophylactic-dose anticoagulation | 44.1 (132) |
| Intermediate-dose anticoagulation | 9.03 (27) |
| Therapeutic-dose anticoagulation | 23.4 (70) |
| Bleeding | 5 (15) |
| Transfusions | |
| Transfusion of blood components | 30.4 (91) |
| Platelet’s transfusion | 7 (21) |
| Fresh-frozen plasma transfusion | 5 (15) |
| ICU | |
| Noninvasive mechanical ventilation | 58.5 (175) |
| Invasive mechanical ventilation | 70.9 (212) |
| Tracheotomy | 47.2 (141) |
| Prone positions | 59.2 (177) |
| Sepsis | 15.4 (46) |
| Deaths | 29 (87) |